California Public Employees Retirement System lifted its holdings in TransEnterix, Inc. (NYSEAMERICAN:TRXC) by 12.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 181,463 shares of the medical instruments supplier’s stock after buying an additional 20,063 shares during the period. California Public Employees Retirement System’s holdings in TransEnterix were worth $791,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Legal & General Group Plc acquired a new stake in TransEnterix during the second quarter valued at $101,000. Amalgamated Bank acquired a new stake in TransEnterix during the second quarter valued at $104,000. Ardsley Advisory Partners acquired a new stake in TransEnterix during the second quarter valued at $109,000. State Board of Administration of Florida Retirement System acquired a new stake in TransEnterix during the second quarter valued at $138,000. Finally, Cozad Asset Management Inc. acquired a new stake in TransEnterix during the second quarter valued at $228,000.
NYSEAMERICAN TRXC opened at $3.22 on Friday. TransEnterix, Inc. has a fifty-two week low of $1.27 and a fifty-two week high of $6.98.
TRXC has been the topic of several recent research reports. LADENBURG THALM/SH SH upgraded TransEnterix from a “neutral” rating to a “buy” rating and set a $5.00 target price on the stock in a report on Friday. Zacks Investment Research upgraded TransEnterix from a “sell” rating to a “hold” rating in a report on Friday. Finally, BTIG Research restated a “hold” rating on shares of TransEnterix in a report on Tuesday, September 25th.
In other news, CFO Joseph P. Slattery sold 4,924 shares of TransEnterix stock in a transaction dated Tuesday, September 25th. The stock was sold at an average price of $7.03, for a total value of $34,615.72. Following the transaction, the chief financial officer now directly owns 4,924 shares in the company, valued at $34,615.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Joseph P. Slattery sold 64,651 shares of TransEnterix stock in a transaction dated Tuesday, October 2nd. The stock was sold at an average price of $5.74, for a total value of $371,096.74. Following the completion of the transaction, the chief financial officer now owns 11,951 shares in the company, valued at $68,598.74. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,909,224 shares of company stock worth $18,271,761.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by WKRB News and is owned by of WKRB News. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.wkrb13.com/2018/11/11/transenterix-inc-trxc-stake-increased-by-california-public-employees-retirement-system.html.
TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.
Featured Article: How to Invest in the Dividend Aristocrat Index
Want to see what other hedge funds are holding TRXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TransEnterix, Inc. (NYSEAMERICAN:TRXC).
Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.